Myodetox Group secures $2M private financing and expands to US

CPE Media News (12/4/2018) – Myodetox Group, a Canadian-based lifestyle therapy brand, has raised $2 million in private funding and opened its first U.S. clinic location in Los Angeles.

The funding is led by a group of private angel investors and will directly support the brand’s expansion into the U.S. market.

Founded by Vinh Pham and Scott Marcaccio in 2017, Toronto based Myodetox is a lifestyle therapy brand with a mission to educate and inspire people to live a better life by taking care of their body. Myodetx now operates nine locations across Toronto, Vancouver, and Los Angeles.

photo credit: Myodetox Group

News Release

Canadian Lifestyle Therapy Brand Myodetox Raises $2M in Private Funding to Enter U.S. Market

An impressive lineup of private angel investors is backing the popular brand, as it brings its innovative approach to total body therapy into the U.S., starting with a Los Angeles location

LOS ANGELES, Dec. 04, 2018 (GLOBE NEWSWIRE) — Myodetox, a Canadian-based lifestyle therapy brand, today announces $2 million in private funding and the opening of its first U.S. clinic location in Los Angeles. The funding is led by a group of private angel investors and will directly support the brand’s expansion into the U.S. market.

Myodetox has revolutionized rehabilitation, physical therapy and mobility with their proven system of manual therapy and movement programming. Developed by pioneering physical therapist Vinh Pham, Myodetox sessions are built around a personalized treatment framework that focuses on proactive and reactive body care, injury prevention, recovery and optimized mobility.

“The rehab and physical therapy industries have seen little change over the last 50 years in the protocols used to assess and treat individual patient needs,” says Vinh Pham, Co-Founder and Chief Creative Officer of Myodetox. “Myodetox improves the traditional methods used to treat pain and injuries and educates people on why taking care of their body is essential to daily life. We couldn’t be more excited to bring our innovative treatment options to the U.S. market.”

Myodetox’s first U.S. location will open in December in the heart of West Hollywood in Los Angeles (8354 Santa Monica Blvd., West Hollywood, CA). The design-forward clinic follows suit to the eight existing locations throughout Canada. Guests will experience upscale amenities, beverages from local brand partners, concierge-style service, custom-designed therapy pods, curated playlists and more. Each 30- or 60-minute treatment session begins with a comprehensive body assessment with an expert therapist trained in the Myodetox system, followed by a carefully programmed treatment plan designed to resolve pain and optimize movement.

“I first sought out Vinh’s treatment system in 2014 because no other therapist was successful in treating my injuries,” said Scott Marcaccio, Co-Founder and CEO of Myodetox. “I was so inspired by my results and Vinh’s vision for the industry that I knew I had to be a part of the team. In 2015, I joined forces with Vinh to help grow Myodetox and share my passion for the brand with others. My story is a true testament to the profound impact Myodetox has on all of its guests, whether they are looking to recover from an injury like I was or prepare better for everyday physical demands.”

To learn more about Myodetox’s recent funding and expansion to the United States, or about the grand opening of the Los Angeles location, visit www.Myodetox.com.

About Myodetox
Created in 2015 in Canada, Myodetox is a lifestyle therapy brand with a mission to educate and inspire people to live a better life by taking care of their body. With nine locations across Toronto, Vancouver, Los Angeles, and future locations on the horizon, Myodetox is leading today’s conversation on why proactive care is essential to your daily life.

PR Contact
Brittany Johnson, Uproar PR
BJohnson@uproarpr.com
312.878.4575 x241

CPE Media News

Private Capital Journal provides Canada's only complete private capital (angel, venture capital, private equity, private/exempt), public financing, M&A, IPO/RTO news and intelligence.